Regeneron Pharmaceuticals
REGN
REGN
1,077 hedge funds and large institutions have $64B invested in Regeneron Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 367 increasing their positions, 416 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.77% more ownership
Funds ownership: 86.12% → 86.9% (+0.77%)
12% less repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 416
21% less call options, than puts
Call options by funds: $1.17B | Put options by funds: $1.49B
Holders
1,077
Holding in Top 10
34
Calls
$1.17B
Puts
$1.49B
Top Buyers
| 1 | +$436M | |
| 2 | +$286M | |
| 3 | +$137M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$92.7M |
| 5 |
Jane Street
New York
|
+$76.3M |
Top Sellers
| 1 | -$272M | |
| 2 | -$258M | |
| 3 | -$122M | |
| 4 |
Two Sigma Advisers
New York
|
-$112M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$82.7M |